标题
Virus-Based Immunotherapy of Glioblastoma
作者
关键词
-
出版物
Cancers
Volume 11, Issue 2, Pages 186
出版商
MDPI AG
发表日期
2019-02-06
DOI
10.3390/cancers11020186
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
- (2018) Stephen J. Russell et al. CANCER CELL
- Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes
- (2018) Malte Mohme et al. CLINICAL CANCER RESEARCH
- T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
- (2018) Karolina Woroniecka et al. CLINICAL CANCER RESEARCH
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells
- (2018) Ross W. Walton et al. JOURNAL OF VIROLOGY
- Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells
- (2018) Cole Peters et al. JOURNAL OF VIROLOGY
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- New glioblastoma heterogeneity atlas — a shared resource
- (2018) Wolfgang Wick et al. Nature Reviews Neurology
- Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC
- (2018) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- Recurrent Glioblastoma Treated with Recombinant Poliovirus
- (2018) Annick Desjardins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
- (2018) Adel Samson et al. Science Translational Medicine
- Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
- (2018) Tomas Garzon-Muvdi et al. Oncotarget
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- Newcastle disease virus enhances the growth-inhibiting and proapoptotic effects of temozolomide on glioblastoma cells in vitro and in vivo
- (2018) Yang Bai et al. Scientific Reports
- Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy
- (2018) Robert A. Berkeley et al. Cancer Immunology Research
- Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
- (2018) Vassilis Genoud et al. OncoImmunology
- Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy
- (2018) Carmela Passaro et al. CLINICAL CANCER RESEARCH
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Zika virus has oncolytic activity against glioblastoma stem cells
- (2017) Zhe Zhu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
- (2017) Karsten Geletneky et al. MOLECULAR THERAPY
- Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma
- (2017) Manuela Silginer et al. NEURO-ONCOLOGY
- Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
- (2017) Jann N Sarkaria et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
- (2017) Quinn T Ostrom et al. NEURO-ONCOLOGY
- OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143
- (2017) D. A. Reardon et al. NEURO-ONCOLOGY
- Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen–specific CTLs
- (2017) Michael C. Brown et al. Science Translational Medicine
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
- (2017) Assia Angelova et al. Viruses-Basel
- MicroRNA203a suppresses glioma tumorigenesis through an ATM-dependent interferon response pathway
- (2017) Chuan He Yang et al. Oncotarget
- Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain
- (2017) Lukxmi Balathasan et al. Molecular Therapy-Oncolytics
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Corticosteroids compromise survival in glioblastoma
- (2016) Kenneth L. Pitter et al. BRAIN
- Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus
- (2016) Mohanraj Ramachandran et al. CLINICAL CANCER RESEARCH
- A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma
- (2016) R. Rampling et al. CLINICAL CANCER RESEARCH
- Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
- (2016) Jennifer E. Kim et al. CLINICAL CANCER RESEARCH
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
- (2016) Sarah B Goldberg et al. LANCET ONCOLOGY
- The role of microglia and macrophages in glioma maintenance and progression
- (2016) Dolores Hambardzumyan et al. NATURE NEUROSCIENCE
- Immunovirotherapy with measles virus strains in combination with anti–PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment
- (2016) Jayson Hardcastle et al. NEURO-ONCOLOGY
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
- (2016) Timothy F. Cloughesy et al. Science Translational Medicine
- Oncolytic viruses as immunotherapy: progress and remaining challenges
- (2016) Laure Aurelian OncoTargets and Therapy
- Rescuing defective tumor-infiltrating T-cell proliferation in glioblastoma patients
- (2016) Song Han et al. Oncology Letters
- Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy
- (2016) T. M. Johanns et al. Cancer Discovery
- Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach
- (2016) T. M. Johanns et al. Cancer Immunology Research
- TGF Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response
- (2015) J. Han et al. CANCER RESEARCH
- The Impact of Macrophage- and Microglia-Secreted TNF on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment
- (2015) W. H. Meisen et al. CLINICAL CANCER RESEARCH
- Pseudoprogression and Immune-Related Response in Solid Tumors
- (2015) Victoria L. Chiou et al. JOURNAL OF CLINICAL ONCOLOGY
- Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps
- (2015) Christina Kober et al. Journal of Translational Medicine
- MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma
- (2015) Miika Martikainen et al. JOURNAL OF VIROLOGY
- Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
- (2015) Norman Woller et al. MOLECULAR THERAPY
- Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling
- (2015) Julia V. Cockle et al. NEURO-ONCOLOGY
- Cellular Factors Promoting Resistance to Effective Treatment of Glioma with Oncolytic Myxoma Virus
- (2014) F. J. Zemp et al. CANCER RESEARCH
- Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
- (2014) A. Muik et al. CANCER RESEARCH
- Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target
- (2014) Melanie Jackson et al. CARCINOGENESIS
- Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
- (2014) Carolien A. Koks et al. INTERNATIONAL JOURNAL OF CANCER
- Immunocompetent murine models for the study of glioblastoma immunotherapy
- (2014) Taemin Oh et al. Journal of Translational Medicine
- Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
- (2014) Hong Jiang et al. PLoS One
- Aging-induced type I interferon response at the choroid plexus negatively affects brain function
- (2014) K. Baruch et al. SCIENCE
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Oncolytic Viruses and Their Application to Cancer Immunotherapy
- (2014) E. A. Chiocca et al. Cancer Immunology Research
- Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response
- (2013) Érika Cosset et al. INTERNATIONAL JOURNAL OF CANCER
- Oncolytic viruses as therapeutic cancer vaccines
- (2013) David L Bartlett et al. Molecular Cancer
- Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor–based orthotopic xenograft mouse models of pediatric glioma
- (2013) Zhigang Liu et al. NEURO-ONCOLOGY
- Resistance to Oncolytic Myxoma Virus Therapy in Nf1−/−/Trp53−/− Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon
- (2013) Franz J. Zemp et al. PLoS One
- Preferential Replication of Systemically Delivered Oncolytic Vaccinia Virus in Focally Irradiated Glioma Xenografts
- (2012) S. J. Advani et al. CLINICAL CANCER RESEARCH
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- Attenuation of Semliki Forest Virus Neurovirulence by MicroRNA-Mediated Detargeting
- (2012) E. Ylosmaki et al. JOURNAL OF VIROLOGY
- Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy
- (2012) C. A. Crane et al. NEURO-ONCOLOGY
- Expression Signature of IFN/STAT1 Signaling Genes Predicts Poor Survival Outcome in Glioblastoma Multiforme in a Subtype-Specific Manner
- (2012) Christine W. Duarte et al. PLoS One
- Role of Type 1 IFNs in Antiglioma Immunosurveillance--Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans
- (2010) M. Fujita et al. CLINICAL CANCER RESEARCH
- Improved Killing of Human High-Grade Glioma Cells by Combining Ionizing Radiation with Oncolytic Parvovirus H-1 Infection
- (2010) Karsten Geletneky et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models
- (2010) K. Geletneky et al. NEURO-ONCOLOGY
- Intravenously Administered Alphavirus Vector VA7 Eradicates Orthotopic Human Glioma Xenografts in Nude Mice
- (2010) Jari E. Heikkilä et al. PLoS One
- Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production
- (2010) T. Alain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of Systemically Administered Oncolytic Vaccinia Virotherapy for Malignant Gliomas Is Enhanced by Combination Therapy with Rapamycin or Cyclophosphamide
- (2009) X. Q. Lun et al. CLINICAL CANCER RESEARCH
- Impaired interferon signaling is a common immune defect in human cancer
- (2009) R. J. Critchley-Thorne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas
- (2008) Peter Forsyth et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now